cvot tirzepatide 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What SURPASS-CVOT: Tirzepatide Bests Dulaglutide for

A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk

(She has since had a positive experience on Mounjaro.) And influencer Remi Bader said that a GLP-1 drug made her so sick she was "throwing up every day" while on the medication

New blood vessels mean more oxygen and nutrient delivery to the damaged area

A daily medication can be better for some people, because it creates the daily habit of taking it at the same time every day, versus having to remember to take something once a week, says Masutto

This is also when lifestyle habits become more important